Aartsma-Rus A, van Putten M. Assessing functional performance in the mdx mouse model. J Vis Exp. 2014;(85). https://doi.org/10.3791/51303

Al-Mshhdani BA, Grounds MD, Arthur PG, Terrill JR. A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle. Antioxidants (Basel). 2021;10(8). https://doi.org/10.3390/antiox10081241

Ananthasubramaniam B, Meijer JH. Regulation of Rest, Rather Than Activity, Underlies Day-Night Activity Differences in Mice. Front Physiol. 2020;11:268. https://doi.org/10.3389/fphys.2020.00268.

Article  PubMed  PubMed Central  Google Scholar 

Aoyagi H, Kajiwara D, Tsunekuni K, Tanaka K, Miyoshi K, Hirasawa N. Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis. Eur J Pharmacol. 2020;875:173030. https://doi.org/10.1016/j.ejphar.2020.173030.

Article  CAS  PubMed  Google Scholar 

Arima M, Fukuda T. Prostaglandin D(2) and T(H)2 inflammation in the pathogenesis of bronchial asthma. Korean J Intern Med. 2011;26(1):8–18. https://doi.org/10.3904/kjim.2011.26.1.8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aritake K, Kado Y, Inoue T, Miyano M, Urade Y. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem. 2006;281(22):15277–86. https://doi.org/10.1074/jbc.M506431200.

Article  CAS  PubMed  Google Scholar 

Bains RS, Wells S, Sillito RR, Armstrong JD, Cater HL, Banks G, Nolan PM. Assessing mouse behaviour throughout the light/dark cycle using automated in-cage analysis tools. J Neurosci Methods. 2018;300:37–47. https://doi.org/10.1016/j.jneumeth.2017.04.014.

Article  PubMed  PubMed Central  Google Scholar 

Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. https://doi.org/10.1038/s41598-017-17204-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barr JT, Tran TB, Rock BM, Wahlstrom JL, Dahal UP. Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter? Drug Metab Dispos. 2020;48(8):613–21. https://doi.org/10.1124/dmd.120.090621.

Article  CAS  PubMed  Google Scholar 

Angulski BB, A., Hosny, N., Cohen, H., Martin, A. A., Hahn, D., Bauer, J., & Metzger, J. M. Duchenne muscular dystrophy: disease mechanism and therapeutic strategies. Front Physiol. 2023;14:1183101. https://doi.org/10.3389/fphys.2023.1183101.

Article  Google Scholar 

Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3), 251–267. https://doi.org/10.1016/S1474-4422(18)30024-3

Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J. 2007;21(9):2195–204. https://doi.org/10.1096/fj.06-7353.com.

Article  CAS  PubMed  Google Scholar 

Chang M, Cai Y, Gao Z, Chen X, Liu B, Zhang C, Yu W, Cao Q, Shen Y, Yao X, Chen X, Sun H. Duchenne muscular dystrophy: pathogenesis and promising therapies. J Neurol. 2023;270(8):3733–49. https://doi.org/10.1007/s00415-023-11796-x.

Article  CAS  PubMed  Google Scholar 

Cheung SW, Bhavnani E, Simmons DG, Bellingham MC, Noakes PG. Perineuronal nets are phagocytosed by MMP-9 expressing microglia and astrocytes in the SOD1(G93A) ALS mouse model. Neuropathol Appl Neurobiol. 2024;50(3):e12982. https://doi.org/10.1111/nan.12982.

Article  CAS  PubMed  Google Scholar 

Christ AN, Labzin L, Bourne GT, Fukunishi H, Weber JE, Sweet MJ, Smythe ML, Flanagan JU. Development and characterization of new inhibitors of the human and mouse hematopoietic prostaglandin D(2) synthases. J Med Chem. 2010;53(15):5536–48. https://doi.org/10.1021/jm100194a.

Article  CAS  PubMed  Google Scholar 

Clark AL. Origin of symptoms in chronic heart failure. Heart. 2006;92(1):12–6. https://doi.org/10.1136/hrt.2005.066886.

Article  CAS  PubMed  Google Scholar 

Collins CA, Morgan JE. Duchenne’s muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int J Exp Pathol. 2003;84(4):165–72. https://doi.org/10.1046/j.1365-2613.2003.00354.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Paepe B, De Bleecker JL. Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy. Mediators Inflamm. 2013;2013:540370. https://doi.org/10.1155/2013/540370.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhindsa JS, McCall AL, Strickland LM, Fusco AF, Kahn AF, ElMallah MK. Motor axonopathies in a mouse model of Duchenne muscular dystrophy. Sci Rep. 2020;10(1):8967. https://doi.org/10.1038/s41598-020-65824-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

da Silva HNM, Covatti C, da Rocha GL, Mizobuti DS, Mancio RD, Hermes TA, Kido LA, Cagnon VHA, Pereira ECL, Minatel E. Oxidative Stress, Inflammation, and Activators of Mitochondrial Biogenesis: Tempol Targets in the Diaphragm Muscle of Exercise Trained-mdx Mice. Front Physiol. 2021;12:649793. https://doi.org/10.3389/fphys.2021.649793.

Article  PubMed  PubMed Central  Google Scholar 

Dixit VD, Yang H, Cooper-Jenkins A, Giri BB, Patel K, Taub DD. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood. 2009;113(21):5202–5. https://doi.org/10.1182/blood-2008-09-181255.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan D. Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy. Mol Ther. 2018;26(10):2337–56. https://doi.org/10.1016/j.ymthe.2018.07.011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7(1):13. https://doi.org/10.1038/s41572-021-00248-3.

Article  PubMed  PubMed Central  Google Scholar 

Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20(1):34–50. https://doi.org/10.1038/cr.2009.139.

Article  CAS  PubMed  Google Scholar 

Edfeldt F, Evenäs J, Lepistö M, Ward A, Petersen J, Wissler L, Rohman M, Sivars U, Svensson K, Perry M, Feierberg I, Zhou XH, Hansson T, Narjes F. Identification of indole inhibitors of human hematopoietic prostaglandin D2 synthase (hH-PGDS). Bioorganic Med Chemi Letters. 2015;25(12):2496–2500. https://doi.org/10.1016/j.bmcl.2015.04.065

Grounds M. (2010, 25/01/2014). Quantification of histopathology in Haemotoxylin and Eosin stained muscle sections. https://www.treat-nmd.org/wp-content/uploads/2023/07/MDX-DMD_M.1.2.007-28.pdf

Grounds MD, Lloyd EM. Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy. J Neuromuscul Dis. 2023;10(6):1013–30. https://doi.org/10.3233/JND-230161.

Article  PubMed  PubMed Central  Google Scholar 

Grounds MD, Terrill JR, Al-Mshhdani BA, Duong MN, Radley-Crabb HG, Arthur PG. Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Dis Model Mech. 2020;13(2). https://doi.org/10.1242/dmm.043638

Hafstad AD, Boardman NT, Lund J, Hagve M, Khalid AM, Wisloff U, Larsen TS, Aasum E. High intensity interval training alters substrate utilization and reduces oxygen consumption in the heart. J Appl Physiol (1985). 2011;111(5):1235–1241. https://doi.org/10.1152/japplphysiol.00594.2011

Hamamura K, Yoshida Y, Oyama K, Li J, Kawano S, Inoue K, Toyooka K, Yamadera M, Matsunaga N, Matsumura T, Aritake K. Hematopoietic Prostaglandin D Synthase Is Increased in Mast Cells and Pericytes in Autopsy Myocardial Specimens from Patients with Duchenne Muscular Dystrophy. Int J Mol Sci. 2021;25(3).

Herbelet S, Rodenbach A, Paepe B, De Bleecker JL. Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents. Int J Mol Sci. 2020;21(13). https://doi.org/10.3390/ijms21134596

Hoxha M. Duchenne muscular dystrophy: Focus on arachidonic acid metabolites. Biomed Pharmacother. 2019;110:796–802. https://doi.org/10.1016/j.biopha.2018.12.034.

Article  CAS  PubMed  Google Scholar 

Katz SD, Zheng H. Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure. J Nucl Cardiol. 2002;9(2):215–25. https://doi.org/10.1067/mnc.2002.123183.

Article  PubMed  Google Scholar 

Kharraz Y, Guerra J, Pessina P, Serrano AL, Munoz-Canoves P. Understanding the process of fibrosis in Duchenne muscular dystr